uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted July 31, 2020

FTC Sues Golden Sunrise for Marketing Deceptive $23,000 Coronavirus Cure

On July 31, 2020, the Federal Trade Commission (FTC) charged Golden Sunrise Nutraceutical, Inc., a California-based company, with deceptively advertising a $23,000 treatment plan as a scientifically proven way to treat COVID-19.

According to the federal complaint against Golden Sunrise, the company began marketing its Emergency D-Virus Plan of Care on billboards, social media, and its website in March of 2020. Golden Sunrise falsely claims that the company's supplements, ImunStem, Aktiffvate, and AnterFeerons are "uniquely qualified to treat and modify the course of the Coronavirus epidemic" and that these products lead to the "disappearance of viral symptoms within two to four days." 

The FTC warned Golden Sunrise in April 2020 to stop making claims that its products can prevent, treat, or cure COVID-19, but the company continues to market the COVID-19 treatment plan. In addition, Golden Sunrise falsely claims that its products and treatment plans are FDA-approved when they are not.

See Related Warnings:

Sellers of Immune Boosters, Vitamin C Warned for Coronavirus Claims

Sellers of Miracle Mineral Solution Criminally Charged With Making Coronavirus Claims

Seller of Hand Sanitizer "Alternative" Warned for Coronavirus Claims

Seller of Thrive "Anti-Viral" Supplement Barred from Making Unproven Coronavirus and Cancer Claims

FTC Charges Seller With Falsely Promising Consumers Next Day Shipping of Face Masks and Other PPE

Sellers of Essential Oils, Hand Sanitizers and More Warned for Coronavirus Claims

Seller of "COVID Supplement Protection Pack" Warned for Coronavirus Claims

For more information, use the link below.